Search Results

Equities Score 25 Bullish

ResMed Stock Gains Momentum Amid Strategic Shifts and Market Resilience

Mar 10, 2026 18:50 UTC
RMD
Medium term

ResMed Inc. (RMD) is showing signs of recovery and strategic momentum, with a 14% stock rise over the past quarter despite broader healthcare sector volatility. Investors are focusing on its expanding global footprint and operational improvements.

  • ResMed reported $783 million in Q4 2025 revenue, a 6.2% YoY increase
  • Operating expenses dropped 23% in Q4 2025 due to supply chain and digital initiatives
  • Asia-Pacific sales grew 12% in Q4 2025, now representing 38% of international revenue
  • RMD’s adjusted EPS of $1.46 exceeded consensus by 9%
  • Stock rose 14% from January 2026 amid sector-wide weakness
  • EV/EBITDA of 11.8x is below sector average of 14.2x

ResMed Inc. (RMD) is emerging as a compelling name in the healthcare technology space, defying recent sector-wide headwinds. The company reported a 6.2% year-over-year increase in revenue during Q4 2025, reaching $783 million, driven by strong demand in sleep apnea diagnostics and treatment devices. This marks the third consecutive quarter of revenue growth, signaling a stabilization after a challenging 2023–2024 period marked by supply chain disruptions and regulatory delays. The company’s operational turnaround is underscored by a 23% reduction in operating expenses in the same period, achieved through digital transformation and supply chain optimization. ResMed also expanded its presence in Asia-Pacific, where sales grew 12% and represent 38% of total international revenue—up from 32% in 2023. These efforts reflect a broader shift toward value-based care and remote patient monitoring, core to ResMed’s long-term strategy. Market analysts note that RMD’s adjusted earnings per share of $1.46 for Q4 2025 exceeded expectations by 9%, contributing to a 14% stock appreciation since January 2026. The company’s enterprise value-to-EBITDA multiple of 11.8x is below the healthcare technology sector average of 14.2x, suggesting potential undervaluation. Institutional ownership has increased by 4.3 percentage points in the last quarter, with major funds accumulating shares during the dip.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Intelligence Terminal AI Assistant Trading Challenge Analysis Market News Pricing
Sign In Get Started
Home
Terminal
AI
Markets
Profile